Cargando…
Growth rate of early-stage hepatocellular carcinoma in patients with chronic liver disease
BACKGROUND/AIMS: The goal of this study was to estimate the growth rate of hepatocellular carcinoma (HCC) and identify the host factors that significantly affect this rate. METHODS: Patients with early-stage HCC (n=175) who underwent two or more serial dynamic imaging studies without any anticancer...
Autores principales: | An, Chansik, Choi, Youn Ah, Choi, Dongil, Paik, Yong Han, Ahn, Sang Hoon, Kim, Myeong-Jin, Paik, Seung Woon, Han, Kwang-Hyub, Park, Mi-Suk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Association for the Study of the Liver
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4612289/ https://www.ncbi.nlm.nih.gov/pubmed/26523271 http://dx.doi.org/10.3350/cmh.2015.21.3.279 |
Ejemplares similares
-
Different Survival of Barcelona Clinic Liver Cancer Stage C Hepatocellular Carcinoma Patients by the Extent of Portal Vein Invasion and the Type of Extrahepatic Spread
por: Sinn, Dong Hyun, et al.
Publicado: (2015) -
Substantial risk of recurrence even after 5 recurrence-free years in early-stage hepatocellular carcinoma patients
por: Kim, Jihye, et al.
Publicado: (2020) -
Advanced Stage Hepatocellular Carcinoma Successfully Treated with Transarterial Radioembolization and Multi-tyrosine Kinase Inhibitor Therapy
por: Goh, Myung Ji, et al.
Publicado: (2020) -
Noncontrast magnetic resonance imaging versus ultrasonography for hepatocellular carcinoma surveillance (MIRACLE-HCC): study protocol for a prospective randomized trial
por: An, Chansik, et al.
Publicado: (2018) -
Metabolic dysfunction-associated fatty liver disease and the risk of hepatocellular carcinoma
por: Song, Byeong Geun, et al.
Publicado: (2023)